CHINA
China | Data exclusivity comes into effect
Protection of Drug Trial Data on 15 May 2026 with immediate effect, i.e. simultaneously with the Implementing Regulations of the Drug Administration Law (2026 Revisions). The enforcement of...
Protection of Drug Trial Data on 15 May 2026 with immediate effect, i.e. simultaneously with the Implementing Regulations...
Read More
GREATER CHINA
China | Punitive damages in intellectual property civil cases
Supreme People Court (SPC) 2026 Judicial Interpretation. The 2026 SPC Interpretation further refines and supplements the rules set out in the 2021 version and addresses practical issues arising in judicial practice over recent years, including determining of...
Supreme People Court (SPC) 2026 Judicial Interpretation. The 2026 SPC Interpretation further refines and supplements the rules set out in the 2021 version and addresses...
Read More
AUSTRALASIA
Extending Protection for Pharmaceuticals | Requirements in Australia, China and Singapore
Our teams across the Asia Pacific explore how pharmaceutical innovators can extend protection for their therapeutic products through patent term extensions (PTEs) and data exclusivity in Australia, China, and Singapore.  A comparison table is provided below which summarises key requirements and timing considerations for...
Our teams across the Asia Pacific explore how pharmaceutical innovators can extend protection for their therapeutic products through patent term extensions (PTEs) and data...
Read More
GREATER CHINA
Guide to protecting your Trade Secrets under China’s new Regulations
On 24 February 2026, China’s State Administration for Market Regulation (“SAMR”) issued the Regulations on the Protection of Trade Secrets (Announcement No. 126 of the State Administration for Market...
On 24 February 2026, China’s State Administration for Market Regulation (“SAMR”) issued the Regulations on the Protection of Trade...
Read More
CHINA
Market Exclusivity and Data Exclusivity included in Drug Administration Law revisions
Marking a milestone in China’s drug regulatory landscape, the 2026 Revisions of China’s Drug Administration Law introduce data exclusivity and market exclusivity into the regulatory framework, establishing a multi‑dimensional...
Marking a milestone in China’s drug regulatory landscape, the 2026 Revisions of China’s Drug Administration Law introduce data exclusivity...
Read More
AUSTRALASIA
International Women’s Day 2026
Rights. Justice. Action. For All Women & Girls. According to the United Nations, "No nation has yet closed the legal gaps between men and women, The 2026 UN theme calls...
Rights. Justice. Action. For All Women & Girls. According to the United Nations, "No nation has yet closed the legal...
Read More
CHINA
Revised Anti-Unfair Competition Law expands Acts of Confusion (2025)
Recent changes to China’s Anti-Unfair Competition Law reshape how businesses can use trade names, branding and search keywords. Practices that are commonly used in digital marketing now carry clearer...
Recent changes to China’s Anti-Unfair Competition Law reshape how businesses can use trade names, branding and search keywords. Practices...
Read More
GREATER CHINA
China | Trade mark ruling extends infringement to digital worlds
As a case involving virtual in-game items, the final ruling in the trade mark infringement and unfair competition dispute between Xuanwo Automotive Technology (Shanghai) Co., Ltd. ("Xuanwo") and several...
As a case involving virtual in-game items, the final ruling in the trade mark infringement and unfair competition dispute...
Read More
GREATER CHINA
Double Patenting: A multi-jurisdictional minefield | China, Hong Kong & Southeast Asia
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject matter, or incremental improvements, so long as the claims are...
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject...
Read More
GREATER CHINA
China | Amendments to Patent Examination Guidelines finalised
After six months of drafting and revisions, the China National Intellectual Property Administration (CNIPA) issued the finalised version of the Guidelines for Patent Examination on 13 November 2025. These revisions will...
After six months of drafting and revisions, the China National Intellectual Property Administration (CNIPA) issued the finalised version of...
Read More
GREATER CHINA
China | Patent rules changed for AI and bitstream
Further to our previous article on proposed changes for AI and bitstream related inventions, China has now released revisions that materially affect examination practices and legal consequences for such...
Further to our previous article on proposed changes for AI and bitstream related inventions, China has now released revisions...
Read More
CHINA
China | New draft trade mark law strengthens brand protection
This article was first published on the IPHQ News website, 24 October 2025. China’s National Intellectual Property Administration (CNIPA) has proposed a new law aimed at strengthening trademark protection....
This article was first published on the IPHQ News website, 24 October 2025. China’s National Intellectual Property Administration (CNIPA)...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe